The Wnt antagonist Frzb-1 regulates chondrocyte maturation and long bone development during limb skeletogenesis.
about
WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repairWnt signaling in cartilage development and diseases: lessons from animal studiesThe Regulatory Role of Signaling Crosstalk in Hypertrophy of MSCs and Human Articular ChondrocytesA pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturationRelating the chondrocyte gene network to growth plate morphology: from genes to phenotypeConditional expression of Wnt4 during chondrogenesis leads to dwarfism in miceBinding of sFRP-3 to EGF in the extra-cellular space affects proliferation, differentiation and morphogenetic events regulated by the two molecules.Nonthermal atmospheric pressure plasma enhances mouse limb bud survival, growth, and elongationNo association of the polymorphisms of the frizzled-related protein gene with peak bone mineral density in Chinese nuclear familiesThe Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering ApplicationsDistribution of slow-cycling cells in epiphyseal cartilage and requirement of β-catenin signaling for their maintenance in growth plate.Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin.Epigenetic alterations in metastatic cutaneous carcinoma.A review of crosstalk between MAPK and Wnt signals and its impact on cartilage regenerationIntervertebral disc development is regulated by Wnt/β-catenin signaling.WNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathwaysGeneration of Col2a1-EGFP iPS cells for monitoring chondrogenic differentiation.Proteomics analysis of the zebrafish skeletal extracellular matrix.Wnt/beta-catenin signaling in oral tissue development and disease.Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling.Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand.Resident mesenchymal progenitors of articular cartilage.Carboxypeptidase Z (CPZ) links thyroid hormone and Wnt signaling pathways in growth plate chondrocytesVariant alleles of the Wnt antagonist FRZB are determinants of hip shape and modify the relationship between hip shape and osteoarthritis.Further evidence of the role of frizzled-related protein gene polymorphisms in osteoarthritis.Tight regulation of wingless-type signaling in the articular cartilage - subchondral bone biomechanical unit: transcriptomics in Frzb-knockout miceCartilage-specific β-catenin signaling regulates chondrocyte maturation, generation of ossification centers, and perichondrial bone formation during skeletal developmentThe importance of foetal movement for co-ordinated cartilage and bone development in utero : clinical consequences and potential for therapy.Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females.Multifaceted signaling regulators of chondrogenesis: Implications in cartilage regeneration and tissue engineeringSmall GTPase protein Rac-1 is activated with maturation and regulates cell morphology and function in chondrocytesLoss of β-catenin induces multifocal periosteal chondroma-like masses in miceRecent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis.The role of Dickkopf-1 in bone development, homeostasis, and diseaseAxin1 and Axin2 are regulated by TGF- and mediate cross-talk between TGF- and Wnt signaling pathways.Wnt-mediated regulation of chondrocyte maturation: modulation by TGF-betaTransforming growth factor-beta stimulates cyclin D1 expression through activation of beta-catenin signaling in chondrocytes.Roles of Wnt pathway genes wls, wnt9a, wnt5b, frzb and gpc4 in regulating convergent-extension during zebrafish palate morphogenesis.Brachy-syndactyly caused by loss of Sfrp2 functionAbnormal expression of chondroitin sulphate N-acetylgalactosaminyltransferase 1 and Hapln-1 in cartilage with Kashin-Beck disease and primary osteoarthritis
P2860
Q24670104-C714C200-06D9-46F5-A29B-17FFB42ED3AFQ26774008-15C6545A-7BD9-4D77-A2FF-BB905AD5F6DDQ26796645-B2499EAE-E197-4E74-9CAA-DA496707805CQ26995910-5A248036-7C4B-474D-804A-087088CF0C37Q27305048-14E23807-D6AB-497C-97E2-CA8749D98F9BQ33284759-74410801-0C40-4F99-8B99-776062DD36A0Q33344470-88731BDE-809F-443B-BCCE-E8FE83685D5BQ33462524-A7B25E78-9DB9-4B70-B811-4041F5C51951Q33521540-7D6BF95A-1A23-44A3-A7C2-550A257FECACQ33851544-D5B1C8C5-50E8-401E-8A39-700682A95D9DQ33964899-730C4BD8-E9B3-48A8-95AF-BD5CEF9FE0FDQ34107237-DD1E66D5-9BE8-418A-BA31-B6DFA1B88A0EQ34283143-E4F9A2A9-E677-456D-83A9-1AD5B658B1C1Q34527178-46EB7877-1FB9-43A4-B016-881B6DEDB56BQ34770625-69A0E4ED-B31B-4B4E-92D0-9F9B97075D1DQ34918244-9F1E732B-337E-421D-853E-BEA576EE9837Q34997218-7F51E35E-234B-497D-9B27-35C4ACB73EA8Q35114668-D2A150F8-6556-458C-AF0C-84901AAAA033Q35119945-368FEEE0-CF59-4DAC-8FAB-0AA62E1659BFQ35170930-0BA319FE-8AF9-4EE0-8273-70D1133356E6Q35547835-51E8B8B2-D5F7-4F6C-A85B-1DC1814C14ECQ35619228-71AF18BD-2380-48A7-BA78-3330B067173DQ35748171-2EFE5454-AEBE-44AE-9F6C-BCAFDD33330AQ35922988-C62FD15D-59B7-4EE9-9ADB-D686643312DDQ35953490-2012E9F4-8F80-4B0A-9CB3-361D19F38CACQ36084937-C0296C98-52D5-481B-96C2-B837539EC953Q36103474-D71A8B13-FD76-4642-B0A5-A846F9A8847FQ36149873-CE17DFD1-8BFB-453C-8175-33ED3D903CE3Q36448809-51EBA4EA-B241-4643-A288-9999A239B907Q36514312-AE094C81-1AE7-4A6B-AE48-5CD4924F3DC6Q36528170-1132D267-A5BD-4F87-83C2-1A7BA8CA03ADQ36676500-750BAB49-5FD0-4E3E-A78D-14CD5E093BE9Q36901003-797B1AFD-6A40-45AE-90A2-A9153D7DAF8BQ37066218-9CAC8C58-517F-40BA-B602-83DA487E9FFCQ37110142-41593C7C-CFC4-4BCB-8253-7F974DF0C5B8Q37113452-4BCE2B4D-AFEB-4BEB-9585-B50FC993DC2FQ37113911-038CFABA-E948-4A2F-A392-22A0B1B4E633Q37120530-FBB37F9A-E6C0-4D29-AC63-5E96E51D756BQ37180939-DBF1E29A-9A46-4470-9857-9DC79790842BQ37189012-5A73E615-65FE-4C0D-A636-18B3B9265D80
P2860
The Wnt antagonist Frzb-1 regulates chondrocyte maturation and long bone development during limb skeletogenesis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
The Wnt antagonist Frzb-1 regu ...... nt during limb skeletogenesis.
@en
The Wnt antagonist Frzb-1 regu ...... nt during limb skeletogenesis.
@nl
type
label
The Wnt antagonist Frzb-1 regu ...... nt during limb skeletogenesis.
@en
The Wnt antagonist Frzb-1 regu ...... nt during limb skeletogenesis.
@nl
prefLabel
The Wnt antagonist Frzb-1 regu ...... nt during limb skeletogenesis.
@en
The Wnt antagonist Frzb-1 regu ...... nt during limb skeletogenesis.
@nl
P2093
P356
P1476
The Wnt antagonist Frzb-1 regu ...... nt during limb skeletogenesis.
@en
P2093
Changshan Wu
Eiki Koyama
Hiroshi Okada
Jirouta Kitagaki
Kojiro Kurisu
Masahiro Iwamoto
Maurizio Pacifici
Motomi Enomoto-Iwamoto
Naoko Kanatani
Philippa H Francis-West
P304
P356
10.1006/DBIO.2002.0802
P407
P577
2002-11-01T00:00:00Z